N-(4-Ethylphenyl)-2-((5-((4-methylpiperazin-1-yl)sulfonyl)pyridin-2-yl)thio)propanamide
95%
- Product Code: 245624
CAS:
869356-20-7
| Molecular Weight: | 448.6 g./mol | Molecular Formula: | C₂₁H₂₈N₄O₃S₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | 1.32±0.1 g/cm3(Predicted) | Storage Condition: | -20°C, Sealed, Inert Gas |
Product Description:
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly those targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in developing treatments for solid tumors due to its ability to modulate signaling pathways linked to tumor growth and metastasis. Also employed in structure-activity relationship (SAR) studies to optimize drug candidates for improved potency and selectivity. Its sulfonamide and piperazine moieties enhance solubility and bioavailability, making it valuable in designing orally active agents. Currently investigated in preclinical models for efficacy against resistant cancer strains.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | Ft300,493.31 |
+
-
|
| 0.001 | 10-20 days | Ft92,386.71 |
+
-
|
| 0.010 | 10-20 days | Ft450,792.51 |
+
-
|
N-(4-Ethylphenyl)-2-((5-((4-methylpiperazin-1-yl)sulfonyl)pyridin-2-yl)thio)propanamide
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly those targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in developing treatments for solid tumors due to its ability to modulate signaling pathways linked to tumor growth and metastasis. Also employed in structure-activity relationship (SAR) studies to optimize drug candidates for improved potency and selectivity. Its sulfonamide and piperazine moieties enhance solubility and bioavailability, making it valuable in designing orally active agents. Currently investigated in preclinical models for efficacy against resistant cancer strains.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :